Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

458 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Kadota K, Colovos C, Suzuki K, Rizk NP, Dunphy MP, Zabor EC, Sima CS, Yoshizawa A, Travis WD, Rusch VW, Adusumilli PS. Kadota K, et al. Among authors: yoshizawa a. Ann Surg Oncol. 2012 Oct;19(11):3598-605. doi: 10.1245/s10434-012-2414-3. Epub 2012 May 30. Ann Surg Oncol. 2012. PMID: 22644511 Free PMC article.
Thyroid transcription factor-1 expression is an independent predictor of recurrence and correlates with the IASLC/ATS/ERS histologic classification in patients with stage I lung adenocarcinoma.
Kadota K, Nitadori J, Sarkaria IS, Sima CS, Jia X, Yoshizawa A, Rusch VW, Travis WD, Adusumilli PS. Kadota K, et al. Among authors: yoshizawa a. Cancer. 2013 Mar 1;119(5):931-8. doi: 10.1002/cncr.27863. Epub 2012 Oct 23. Cancer. 2013. PMID: 23096929 Free PMC article.
Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages.
Sumiyoshi S, Yoshizawa A, Sonobe M, Kobayashi M, Fujimoto M, Tsuruyama T, Date H, Haga H. Sumiyoshi S, et al. Among authors: yoshizawa a. Lung Cancer. 2013 Jul;81(1):53-9. doi: 10.1016/j.lungcan.2013.04.003. Epub 2013 Apr 28. Lung Cancer. 2013. PMID: 23632273 Clinical Trial.
458 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page